A Chromosome-Protecting Protein Also Keeps Muscle Stem Cells Able to Repair Damaged Tissue

Mice in a Duchenne muscular dystrophy model experienced faster muscle degeneration and shorter survival after TRF2 was removed.
The cells stayed alive but lost the identity that let them repair muscle
Mice lacking TRF2 in muscle stem cells could not rebuild injured muscle, which filled with fat and scar.
Mark

Why is this a surprise? TRF2 was already a well-studied protein.

Mimi

Because its known job was guarding chromosome ends. Here it turns out to help muscle stem cells keep their identity, which is a different kind of role.

Mark

And what does losing that identity look like?

Mimi

The cells don't die. They stay alive but stop functioning as muscle stem cells, so injured muscle fills with fat and scar rather than new muscle.

Luke

The muscles looked normal at first, right? So the damage only shows up when there's an injury to repair?

Mimi

Yes. The stem cell population declined over time, and the problem became clear after injury.

Mark

What about the muscular dystrophy angle?

Mimi

In a Duchenne mouse model, removing TRF2 made degeneration faster and shortened survival.

Luke

I'd keep that in proportion. It's mice, and the source says plainly it doesn't establish a treatment. Whether this holds in people is unknown.

Mark

And the cancer connection?

Mimi

It's a question more than a finding. Muscle regenerates well but rarely gives rise to cancer, and TRF2 might help explain that.

Luke

Right, researchers believe it could offer clues. That's a hypothesis they're going to test, not a result.

  • Mice without the protein TRF2 looked healthy at first, but the damage showed up only when their muscles were hurt and could not rebuild.
  • Injured tissue filled with fat and scar, a quiet failure that spread through the body's reserve of repair cells.
  • In a Duchenne muscular dystrophy model, the loss of TRF2 sped up muscle decay and shortened survival.
  • Researchers are tracing the mechanism through G-quadruplex structures in DNA, aiming to turn the discovery toward therapies.
  • The work remains in mice, so its path to people is still open and unproven.

Some proteins are known for guarding the ends of our chromosomes, and it is a quiet surprise to learn that one of them also helps muscle stem cells remember what they are for. In mice, when this protein was removed, the cells survived but lost their muscle identity, so injured muscle healed with fat and scar instead of new fiber. The finding, reported by researchers at the University of Pennsylvania, offers a glimpse of how the body keeps its reserve for repair intact, and it arrives at a time when families living with Duchenne muscular dystrophy are waiting for any path toward slowing a disease that has long resisted it.

In mice whose muscle stem cells had been stripped of a protein called TRF2, the muscles appeared normal at first. The problem surfaced only when the muscles were injured and the animals could not rebuild them. Where new muscle should have grown, the damaged tissue filled with fat and scar.

The research, from the Perelman School of Medicine at the University of Pennsylvania and published in Science Advances, reveals a second role for a protein long known for protecting the ends of chromosomes. TRF2 helps muscle stem cells hold on to the genetic instructions that define them. Those cells are the body's repair reserve, normally resting and then awakening after injury to rebuild tissue before returning to dormancy. The researchers found that TRF2 levels shift as cells move through these stages.

When the protein was removed, the cells did not die, as the team had expected. They survived but lost the identity that let them repair muscle, and the animals' ability to recover steadily declined. The same loss proved especially harmful in a mouse model of Duchenne muscular dystrophy, where muscle degeneration accelerated and survival shortened.

The team's experiments suggest how TRF2 works. It binds regulatory regions across the genome, including G-quadruplex structures that influence which genes are active. Through them, the protein appears to maintain the gene activity pattern that keeps stem cells ready to repair. The researchers also see a possible link to a puzzle: skeletal muscle regenerates remarkably well, yet muscle cancers are rare, and comparing TRF2's role across tissues may help explain that balance.

These results are not a treatment. The work was done in mice, and whether it applies to people remains to be seen. For now, the team is weighing what the protein's role might mean for muscular dystrophy and for understanding cancer in more vulnerable tissues.

In mice whose muscle stem cells had been stripped of a protein called TRF2, the muscles looked normal at first. Nothing seemed wrong. The trouble showed up later, when the muscles were injured and the animals could not rebuild them. Instead of new muscle, the damaged tissue filled with fat and scar.

The finding comes from researchers at the Perelman School of Medicine at the University of Pennsylvania, who published it in Science Advances. TRF2 has long been studied for what it does at telomeres, the protective structures at the ends of chromosomes that keep those ends from deteriorating or being mistaken for damaged DNA. The Penn team has now shown that the protein has a second job: it helps muscle stem cells hold on to the genetic instructions that make them muscle stem cells.

That identity matters because these cells are the body's reserve for repair. Normally they spend much of their time dormant. After an injury they activate, multiply, and help replace damaged tissue, and some then return to rest, keeping a pool available for the next injury. In laboratory experiments, the researchers found that TRF2 levels rise and fall as cells move through these stages, which suggests the protein helps regulate the whole regeneration cycle.

When the team removed TRF2 from muscle stem cells in mice, the number of functional stem cells declined over time, and the animals grew less able to repair injured muscle. The researchers had expected the cells to die, since losing TRF2 can have that effect in other tissues. They did not. The cells stayed alive but lost the molecular identity that let them work as muscle stem cells. "The loss of identity has severe implications for whether recovery from injury is even possible," said senior author Foteini Mourkioti, PhD, an associate professor of Orthopedic Surgery at Penn Medicine.

The team then turned to Duchenne muscular dystrophy, an inherited disorder that causes progressive muscle weakness and degeneration. In a mouse model of the disease, removing TRF2 from muscle stem cells made things dramatically worse. Muscle degeneration progressed much faster, and the mice survived for a shorter time. The result indicates that TRF2 helps preserve the regenerative capacity of muscles already under strain from a serious genetic condition.

Further experiments pointed to how the protein does this. Although TRF2 is best known for its work at chromosome ends, it also attaches to regulatory regions across the genome, the stretches of DNA that help control which genes are switched on or off. Many of those regions contain G-quadruplexes, unusual structures formed when guanine-rich DNA folds into arrangements involving four interacting strands or segments. These structures are of wide scientific interest because they can influence gene function, and they are being investigated as possible cancer targets. According to the researchers, TRF2 works through them to maintain the pattern of gene activity that keeps muscle stem cells capable of repair. "That was completely unexpected," Mourkioti said.

The work may also bear on a puzzle in muscle biology. Skeletal muscle regenerates impressively well, yet cancers that begin in skeletal muscle are relatively rare, while other tissues with heavy regenerative activity tend to be more vulnerable. The researchers believe TRF2's role in muscle stem cells could offer clues, and comparing how it regulates genes in muscle and in other tissues may show how strong repair can coexist with limits on uncontrolled growth.

The results do not amount to a treatment. The work was done in mice, and more research is needed to learn whether it translates to people. Mourkioti and her colleagues are now exploring whether the way muscle stem cells use TRF2 could suggest strategies for muscular dystrophy, and what the mechanism might reveal about cancer in more susceptible tissues. The research was supported by grants from the National Institutes of Health, including the National Institute of Arthritis and Musculoskeletal and Skin Diseases.

The loss of identity has severe implications for whether recovery from injury is even possible.
— Foteini Mourkioti, PhD, Penn Medicine
Quer a matéria completa? Leia o original em Science Daily ↗
Fale Conosco FAQ